117 related articles for article (PubMed ID: 27435681)
1. Predicting the in vivo accumulation of nanoparticles in tumor based on in vitro macrophage uptake and circulation in zebrafish.
Chang H; Yhee JY; Jang GH; You DG; Ryu JH; Choi Y; Na JH; Park JH; Lee KH; Choi K; Kim K; Kwon IC
J Control Release; 2016 Dec; 244(Pt B):205-213. PubMed ID: 27435681
[TBL] [Abstract][Full Text] [Related]
2. Zebrafish as a model system for characterization of nanoparticles against cancer.
Evensen L; Johansen PL; Koster G; Zhu K; Herfindal L; Speth M; Fenaroli F; Hildahl J; Bagherifam S; Tulotta C; Prasmickaite L; Mælandsmo GM; Snaar-Jagalska E; Griffiths G
Nanoscale; 2016 Jan; 8(2):862-77. PubMed ID: 26648525
[TBL] [Abstract][Full Text] [Related]
3. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
Fan C; Gao W; Chen Z; Fan H; Li M; Deng F; Chen Z
Int J Pharm; 2011 Feb; 404(1-2):180-90. PubMed ID: 21087660
[TBL] [Abstract][Full Text] [Related]
4. Pretargeting with bispecific fusion proteins facilitates delivery of nanoparticles to tumor cells with distinct surface antigens.
Yang Q; Parker CL; Lin Y; Press OW; Park SI; Lai SK
J Control Release; 2017 Jun; 255():73-80. PubMed ID: 28363519
[TBL] [Abstract][Full Text] [Related]
5. Precise Targeting of Liver Tumor Using Glycol Chitosan Nanoparticles: Mechanisms, Key Factors, and Their Implications.
Na JH; Koo H; Lee S; Han SJ; Lee KE; Kim S; Lee H; Lee S; Choi K; Kwon IC; Kim K
Mol Pharm; 2016 Nov; 13(11):3700-3711. PubMed ID: 27654060
[TBL] [Abstract][Full Text] [Related]
6. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
7. Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy.
Bisht S; Maitra A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):415-25. PubMed ID: 20049807
[TBL] [Abstract][Full Text] [Related]
8. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
[TBL] [Abstract][Full Text] [Related]
9. Differential Nanoparticle Sequestration by Macrophages and Scavenger Endothelial Cells Visualized
Hayashi Y; Takamiya M; Jensen PB; Ojea-Jiménez I; Claude H; Antony C; Kjaer-Sorensen K; Grabher C; Boesen T; Gilliland D; Oxvig C; Strähle U; Weiss C
ACS Nano; 2020 Feb; 14(2):1665-1681. PubMed ID: 31922724
[TBL] [Abstract][Full Text] [Related]
10. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles.
Park K; Kim JH; Nam YS; Lee S; Nam HY; Kim K; Park JH; Kim IS; Choi K; Kim SY; Kwon IC
J Control Release; 2007 Oct; 122(3):305-14. PubMed ID: 17643545
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking.
Duan X; Li Y
Small; 2013 May; 9(9-10):1521-32. PubMed ID: 23019091
[TBL] [Abstract][Full Text] [Related]
12. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H
Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163
[TBL] [Abstract][Full Text] [Related]
13. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Lee JH; Kim K; Kwon IC; Kim DD
Biomaterials; 2011 Oct; 32(29):7181-90. PubMed ID: 21733572
[TBL] [Abstract][Full Text] [Related]
15. In vivo targeted delivery of nanoparticles for theranosis.
Koo H; Huh MS; Sun IC; Yuk SH; Choi K; Kim K; Kwon IC
Acc Chem Res; 2011 Oct; 44(10):1018-28. PubMed ID: 21851104
[TBL] [Abstract][Full Text] [Related]
16. PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo.
Choi KY; Min KH; Yoon HY; Kim K; Park JH; Kwon IC; Choi K; Jeong SY
Biomaterials; 2011 Mar; 32(7):1880-9. PubMed ID: 21159377
[TBL] [Abstract][Full Text] [Related]
17. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
[TBL] [Abstract][Full Text] [Related]
18. Zebrafish as an early stage screening tool to study the systemic circulation of nanoparticulate drug delivery systems in vivo.
Sieber S; Grossen P; Detampel P; Siegfried S; Witzigmann D; Huwyler J
J Control Release; 2017 Oct; 264():180-191. PubMed ID: 28851572
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
20. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
